Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapy.

BACKGROUND We report on a Phase 1 trial of photodynamic therapy (PDT) for superficial head and neck (H&N) lesions. Due to known oxygen dependencies of PDT, translational measurements of lesion hemoglobin oxygen saturation (StO2) and blood volume (tHb) were studied for associations with patient outcomes. METHODS PDT with aminolevulinc acid (ALA) and escalating light doses was evaluated for high-grade dysplasia, carcinoma-in-situ, and microinvasive carcinomas of the H&N. Among 29 evaluable patients, most (18) had lesions of the tongue or floor of mouth (FOM). Disease was intact in 18 patients and present at surgical margins in 11 patients. In 26 patients, lesion StO2 and tHb was measured. RESULTS Local control (LC) at 24 months was 57.5% among all patients. In patients with tongue/FOM lesions LC was 42.7%, and it was 50.1% for those with intact lesions. Lesion tHb was not associated with 3-month complete response (CR), but StO2 was higher in patients with CR. In tongue/FOM lesions, baseline StO2 [mean(SE)] was 54(4)% in patients (n=12) with CR versus 23(8)% in patients (n=6) with local recurrence/persistence (p=0.01). Similarly, for intact disease, baseline StO2 was 54(3)% in patients (n=10) with CR versus 28(8)% in patients (n=5) without CR (p=0.03). In patients with intact disease, higher baseline StO2 associated with 24-month local control (p=0.02). CONCLUSIONS Measurement of the physiologic properties of target lesions may allow for identification of patients with the highest probability of benefiting from PDT. This provides opportunity for optimizing light delivery based on lesion characteristics and/or informing ongoing clinical decision-making in patients who would most benefit from PDT.

[1]  James B. Mitchell,et al.  Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugates. , 2015, Free radical biology & medicine.

[2]  Michele T. Cooper,et al.  Photodynamic therapy for head and neck dysplasia and cancer. , 2009, Archives of otolaryngology--head & neck surgery.

[3]  I. Tan,et al.  mTHPC‐mediated photodynamic therapy for early oral squamous cell carcinoma , 2004, International journal of cancer.

[4]  W. Jerjes,et al.  Photodynamic therapy in the management of potentially malignant and malignant oral disorders , 2012, Head & neck oncology.

[5]  W. Jerjes,et al.  Photodynamic therapy outcome for oral dysplasia , 2011, Lasers in surgery and medicine.

[6]  A. Sieroń,et al.  Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia. , 2011, Photodiagnosis and photodynamic therapy.

[7]  Avigdor Scherz,et al.  Light‐dependent Oxygen Consumption in Bacteriochlorophyll‐Serine‐treated Melanoma Tumors: On‐line Determination Using a Tissue‐inserted Oxygen Microsensor , 1997, Photochemistry and photobiology.

[8]  B W Henderson,et al.  Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. , 1987, Cancer research.

[9]  Jarod C Finlay,et al.  Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic Therapy , 2015, Photochemistry and photobiology.

[10]  Bruce J. Tromberg,et al.  Monitoring Tumor Response During Photodynamic Therapy Using Near-infrared Photon-migration Spectroscopy¶ , 2001, Photochemistry and Photobiology.

[11]  J. Severinghaus.  Simple, accurate equations for human blood O2 dissociation computations. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[12]  Brian W Pogue,et al.  Tumor PO(2) changes during photodynamic therapy depend upon photosensitizer type and time after injection. , 2002, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[13]  Timothy C Zhu,et al.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy , 2009, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[14]  Timothy C Zhu,et al.  Evaluation of the 2‐(1‐Hexyloxyethyl)‐2‐devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling , 2016, Journal of biophotonics.

[15]  M Schemper,et al.  A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.

[16]  Adrian Mariampillai,et al.  Interstitial Doppler optical coherence tomography as a local tumor necrosis predictor in photodynamic therapy of prostatic carcinoma: an in vivo study. , 2008, Cancer research.

[17]  K. Soo,et al.  Hemodynamic monitoring of Chlorin e6-mediated photodynamic therapy using diffuse optical measurements. , 2014, Journal of photochemistry and photobiology. B, Biology.

[18]  M. Biel,et al.  Photodynamic Therapy Treatment of Early Oral and Laryngeal Cancers † , 2007, Photochemistry and photobiology.

[19]  Ulas Sunar,et al.  Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma , 2016, Journal of biomedical optics.

[20]  J. Roodenburg,et al.  Non-invasive measurement of the microvascular properties of non-dysplastic and dysplastic oral leukoplakias by use of optical spectroscopy. , 2011, Oral oncology.

[21]  Steen Jakobsen,et al.  FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  D. Aust,et al.  Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG , 2016, Clinical Cancer Research.

[23]  T. Busch,et al.  Local physiological changes during photodynamic therapy , 2006, Lasers in surgery and medicine.

[24]  J. Woodhams,et al.  The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[25]  J. Mourant,et al.  Predictions and measurements of scattering and absorption over broad wavelength ranges in tissue phantoms. , 1997, Applied optics.

[26]  F. Hetzel,et al.  Hyperoxygenation Enhances the Tumor Cell Killing of Photofrin-mediated Photodynamic Therapy¶ , 2003, Photochemistry and photobiology.

[27]  E. Szabo,et al.  A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. , 2013, Oral oncology.

[28]  M G Nichols,et al.  Quantitative broadband near-infrared spectroscopy of tissue-simulating phantoms containing erythrocytes. , 1998, Physics in medicine and biology.

[29]  Ulas Sunar,et al.  Interlesion differences in the local photodynamic therapy response of oral cavity lesions assessed by diffuse optical spectroscopies , 2012, Biomedical optics express.

[30]  Colin Hopper,et al.  mTHPC-mediated Photodynamic Therapy of Early Stage Oral Squamous Cell Carcinoma: A Comparison to Surgical Treatment , 2013, Annals of Surgical Oncology.

[31]  P. Speight,et al.  Photodynamic therapy using 5‐aminolevulinic acid for premalignant and malignant lesions of the oral cavity , 1996, Cancer.

[32]  Jarod C Finlay,et al.  Hemoglobin oxygen saturations in phantoms and in vivo from measurements of steady-state diffuse reflectance at a single, short source-detector separation. , 2004, Medical physics.

[33]  M. Adamek,et al.  Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[34]  G. Weinstein,et al.  Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors. , 2016, Oral oncology.

[35]  M. Biel,et al.  Photodynamic therapy of head and neck cancers. , 2010, Methods in molecular biology.

[36]  J. Roodenburg,et al.  Non-invasive measurement of the morphology and physiology of oral mucosa by use of optical spectroscopy. , 2007, Oral oncology.

[37]  Michael J. Emanuele,et al.  Treatment-Induced Changes in Tumor Oxygenation Predict Photodynamic Therapy Outcome , 2004, Cancer Research.

[38]  C. Hopper,et al.  Photodynamic therapy in the management of lesions of the head and neck. , 2013, The British journal of oral & maxillofacial surgery.

[39]  Y. Wong,et al.  Quantitative physiology and immunohistochemistry of oral lesions. , 2013, Biomedical optics express.